NCTC
GILD icon

New Covenant Trust Company’s Gilead Sciences GILD Stock Holding History

New Covenant Trust Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-844
Closed -$61.8K – 216
2024
Q1 		$61.8K Buy
+844
New +$64.9K 0.06% 159

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New Covenant Trust Company's GILD Position: Q2 2024 in Review

New Covenant Trust Company sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 844 shares — an estimated $61.8K sold.

New Covenant Trust Company first reported a position in GILD in Q1 2024 and held it in 1 quarter. The position peaked at $61.8K in Q1 2024. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • New Covenant Trust Company reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • New Covenant Trust Company sold 844 Gilead Sciences shares in Q2 2024, an estimated $61.8K.
  • New Covenant Trust Company first reported a position in Gilead Sciences in Q1 2024 and held it in 1 quarter.
  • New Covenant Trust Company's Gilead Sciences position peaked at $61.8K in Q1 2024.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on New Covenant Trust Company's 13F filing for Q2 2024, filed 30 Jul 2024.